HPS Pharmacies wish to give notice that Cipla, in consultation with the Therapeutic Goods Administration (TGA), has initiated an urgent product quarantine for Cipla Hydrocortisone 100mg Vials as follows:
Cipla Hydrocortisone Vials
Hydrocortisone (as sodium succinate) 100mg
ARTG 373394
This drug quarantine was initiated due to the discovery of an unknown contaminant.
The only batch affected by this notice is HY0082401A, with an expiry date of 04/2026.
Please inspect your stock and quarantine any stock from the affected batch. If HPS Pharmacies provide imprest management services to your facility, an HPS representative will inspect all stock stored in the designated imprest areas at the earliest opportunity. All affected products will be quarantined and must not be used at this time. Further instructions will be provided once the results of Cipla’s investigation are known. An HPS Pharmacies staff member will contact senior medical and nursing staff if there is an immediate impact to your facility.
Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Cipla on (03) 9696 4438 9 or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates